207 related articles for article (PubMed ID: 8304046)
21. Microgravity reduces the differentiation of human osteoblastic MG-63 cells.
Carmeliet G; Nys G; Bouillon R
J Bone Miner Res; 1997 May; 12(5):786-94. PubMed ID: 9144345
[TBL] [Abstract][Full Text] [Related]
22. The effects of 1,25-dihydroxyvitamin D3 on growth, alkaline phosphatase and adenylate cyclase of rat osteoblast-like cells.
Pols HA; Schilte HP; Herrmann-Erlee NM; Visser TJ; Birkenhäger JC
Bone Miner; 1986 Oct; 1(5):397-405. PubMed ID: 2849488
[TBL] [Abstract][Full Text] [Related]
23. 1,25-Dihydroxyvitamin D3 inhibits myelopoiesis but not B-lymphopoiesis in long-term bone marrow cultures.
Dorshkind K; Reichel H; Norman AW
Exp Hematol; 1989 Jun; 17(5):436-42. PubMed ID: 2785458
[TBL] [Abstract][Full Text] [Related]
24. Modulation of osteogenesis and adipogenesis by human serum in human bone marrow cultures.
Oreffo RO; Virdi AS; Triffitt JT
Eur J Cell Biol; 1997 Nov; 74(3):251-61. PubMed ID: 9402473
[TBL] [Abstract][Full Text] [Related]
25. Phenotypic effects of continuous or discontinuous treatment with dexamethasone and/or calcitriol on osteoblasts differentiated from rat bone marrow stromal cells.
Atmani H; Audrain C; Mercier L; Chappard D; Basle MF
J Cell Biochem; 2002; 85(3):640-50. PubMed ID: 11968004
[TBL] [Abstract][Full Text] [Related]
26. Development and characterization of conditionally immortalized osteoblast precursor cell lines from human bone marrow stroma.
Hicok KC; Thomas T; Gori F; Rickard DJ; Spelsberg TC; Riggs BL
J Bone Miner Res; 1998 Feb; 13(2):205-17. PubMed ID: 9495513
[TBL] [Abstract][Full Text] [Related]
27. Effects of transforming growth factor beta (TGF beta) and 1,25 dihydroxyvitamin D3 on the function, cytochemistry and morphology of normal human osteoblast-like cells.
Ingram RT; Bonde SK; Riggs BL; Fitzpatrick LA
Differentiation; 1994 Jan; 55(2):153-63. PubMed ID: 8143932
[TBL] [Abstract][Full Text] [Related]
28. 24R,25-dihydroxyvitamin D3 increases cyclic GMP contents, leading to an enhancement of osteocalcin synthesis by 1,25-dihydroxyvitamin D3 in cultured human osteoblastic cells.
Yamamoto T; Ozono K; Shima M; Yamaoka K; Okada S
Exp Cell Res; 1998 Oct; 244(1):71-6. PubMed ID: 9770350
[TBL] [Abstract][Full Text] [Related]
29. Effect of 1,25-dihydroxyvitamin D3 on the proliferation of osteoblastic MC3T3-E1 cells by modulating the release of local regulators from monocytes.
Kanatani M; Sugimoto T; Fukase M; Chihara K
Biochem Biophys Res Commun; 1993 Jan; 190(2):529-35. PubMed ID: 8427595
[TBL] [Abstract][Full Text] [Related]
30. Effect of platelet-derived growth factor on DNA synthesis and gene expression in bone marrow stromal cells derived from adult and old rats.
Tanaka H; Liang CT
J Cell Physiol; 1995 Aug; 164(2):367-75. PubMed ID: 7622582
[TBL] [Abstract][Full Text] [Related]
31. Effect of ipriflavone on expression of markers characteristic of the osteoblast phenotype in rat bone marrow stromal cell culture.
Notoya K; Yoshida K; Tsukuda R; Taketomi S
J Bone Miner Res; 1994 Mar; 9(3):395-400. PubMed ID: 8191934
[TBL] [Abstract][Full Text] [Related]
32. Importance of 1,25-dihydroxyvitamin D3 and the nonadherent cells of marrow for osteoblast differentiation from rat marrow stromal cells.
Rickard DJ; Kazhdan I; Leboy PS
Bone; 1995 Jun; 16(6):671-8. PubMed ID: 7669445
[TBL] [Abstract][Full Text] [Related]
33. The effects of dexamethasone and 1,25-dihydroxyvitamin D3 on osteogenic differentiation of human marrow stromal cells in vitro.
Beresford JN; Joyner CJ; Devlin C; Triffitt JT
Arch Oral Biol; 1994 Nov; 39(11):941-7. PubMed ID: 7695507
[TBL] [Abstract][Full Text] [Related]
34. Pretreatment with low doses of norethindrone potentiates the osteogenic effects of fluoride on human osteosarcoma cells.
Takada J; Baylink DJ; Lau KH
J Bone Miner Res; 1995 Oct; 10(10):1512-22. PubMed ID: 8686507
[TBL] [Abstract][Full Text] [Related]
35. Stimulation of bone formation in osteoporosis patients treated with fluoride associated with increased DNA synthesis by osteoblastic cells in vitro.
Marie PJ; De Vernejoul MC; Lomri A
J Bone Miner Res; 1992 Jan; 7(1):103-13. PubMed ID: 1549953
[TBL] [Abstract][Full Text] [Related]
36. Bone marrow cells are targets for the anabolic actions of prostaglandin E2 on bone: induction of a transition from nonadherent to adherent osteoblast precursors.
Scutt A; Bertram P
J Bone Miner Res; 1995 Mar; 10(3):474-87. PubMed ID: 7785470
[TBL] [Abstract][Full Text] [Related]
37. 1,25-Dihydroxyvitamin D3 and human bone-derived cells in vitro: effects on alkaline phosphatase, type I collagen and proliferation.
Beresford JN; Gallagher JA; Russell RG
Endocrinology; 1986 Oct; 119(4):1776-85. PubMed ID: 3489608
[TBL] [Abstract][Full Text] [Related]
38. Lack of a direct effect of estrogen on proliferation and differentiation of normal human osteoblast-like cells.
Keeting PE; Scott RE; Colvard DS; Han IK; Spelsberg TC; Riggs BL
J Bone Miner Res; 1991 Mar; 6(3):297-304. PubMed ID: 2035356
[TBL] [Abstract][Full Text] [Related]
39. Differentiation of heterogeneous phenotypes in human osteoblast cultures in response to 1,25-dihydroxyvitamin D3.
Thavarajah M; Evans DB; Kanis JA
Bone; 1993; 14(5):763-7. PubMed ID: 7505605
[TBL] [Abstract][Full Text] [Related]
40. 1,25 dihydroxyvitamin-D3 attenuates the confluence-dependent differences in the osteoblast characteristic proteins alkaline phosphatase, procollagen I peptide, and osteocalcin.
Siggelkow H; Schulz H; Kaesler S; Benzler K; Atkinson MJ; Hüfner M
Calcif Tissue Int; 1999 May; 64(5):414-21. PubMed ID: 10203418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
